Therapeutic Area | MeSH |
---|---|
eye diseases | D005128 |
Brand Name | Status | Last Update |
---|---|---|
advanced eye relief/ redness maximum relief | C200263 | 2024-09-25 |
alcon tears lubricant eye drops | C200263 | 2023-12-14 |
artificial tears | OTC monograph final | 2019-10-28 |
aurovisc | C200263 | 2024-01-27 |
aurovisc lubricant hypromellose 2208 (15000 mpa.s) gel/drops | C200263 | 2024-01-12 |
aurovisc lubricant hypromellose 2208 (15000 mpa.s) solution/drops | OTC monograph final | 2023-01-11 |
biomedic artificial tears | Export only | 2023-03-17 |
bion tears | C200263 | 2023-12-14 |
clear eyes complete 7 symptom relief | OTC monograph final | 2010-08-15 |
clear eyes complete 7 sympton relief | C200263 | 2024-10-25 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Dry eye syndromes | D015352 | — | H04.12 | 11 | 19 | 12 | 40 | 74 | 151 |
Keratoconjunctivitis sicca | D007638 | EFO_1000906 | — | 8 | 16 | 11 | 26 | 45 | 102 |
Eye diseases | D005128 | EFO_0003966 | H44 | 4 | 9 | 8 | 11 | 21 | 51 |
Glaucoma | D005901 | EFO_0000516 | H40 | 1 | 4 | 3 | 12 | 7 | 26 |
Conjunctivitis | D003231 | HP_0000509 | H10 | — | 2 | 3 | 13 | 4 | 21 |
Meibomian gland dysfunction | D000080343 | — | H02.88 | 2 | 2 | — | 5 | 11 | 18 |
Syndrome | D013577 | — | — | 3 | 7 | 2 | 2 | 6 | 17 |
Healthy volunteers/patients | — | — | — | 8 | — | 1 | 1 | 6 | 16 |
Cataract | D002386 | HP_0000518 | H26.9 | 1 | — | — | 6 | 6 | 13 |
Allergic conjunctivitis | D003233 | EFO_0007141 | H10.44 | — | 1 | — | 12 | — | 13 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Niemann-pick diseases | D009542 | — | E75.24 | 6 | 7 | 4 | — | — | 11 |
Type a niemann-pick disease | D052536 | EFO_1001380 | E75.240 | 6 | 7 | 4 | — | — | 11 |
Type c niemann-pick disease | D052556 | Orphanet_646 | E75.242 | 6 | 7 | 4 | — | — | 11 |
Pick disease of the brain | D020774 | EFO_0003096 | G31.01 | 6 | 7 | 4 | — | — | 11 |
Depression | D003863 | — | F33.9 | — | 5 | 1 | — | 1 | 7 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 5 | 1 | — | 1 | 7 |
Ulcer | D014456 | MPATH_579 | — | 2 | 3 | 3 | — | 2 | 7 |
Frontotemporal dementia | D057180 | HP_0002145 | G31.0 | 6 | 3 | 1 | — | — | 7 |
Primary progressive aphasia | D018888 | EFO_0009053 | G31.01 | 6 | 3 | 1 | — | — | 7 |
Covid-19 | D000086382 | — | — | 2 | 4 | 1 | — | 1 | 6 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Recurrence | D012008 | — | — | — | 4 | — | — | 1 | 5 |
Sjogren's syndrome | D012859 | EFO_0000699 | M35.0 | 1 | 2 | — | — | 2 | 4 |
Fuchs' endothelial dystrophy | D005642 | EFO_0003946 | H18.51 | — | 3 | — | — | 1 | 4 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 2 | — | — | — | 3 |
Leukemia | D007938 | — | C95 | — | 3 | — | — | — | 3 |
Myelodysplastic syndromes | D009190 | — | D46 | — | 3 | — | — | — | 3 |
Myeloid leukemia acute | D015470 | — | C92.0 | — | 3 | — | — | — | 3 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | — | 3 | — | — | — | 3 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | — | 3 | — | — | — | 3 |
Myeloid leukemia | D007951 | — | C92 | — | 3 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hiv | D006678 | — | — | 2 | — | — | — | — | 2 |
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Gastrointestinal diseases | D005767 | — | — | 1 | — | — | — | 1 | 2 |
Immunologic deficiency syndromes | D007153 | HP_0002721 | D84.9 | 1 | — | — | — | — | 1 |
Lipodystrophy | D008060 | HP_0009125 | E88.1 | 1 | — | — | — | — | 1 |
Hiv-associated lipodystrophy syndrome | D039682 | EFO_1001348 | — | 1 | — | — | — | — | 1 |
Medication adherence | D055118 | EFO_0006344 | — | 1 | — | — | — | — | 1 |
Aspergillosis | D001228 | EFO_0007157 | B44 | 1 | — | — | — | — | 1 |
Allergic bronchopulmonary aspergillosis | D001229 | EFO_0007140 | B44.81 | 1 | — | — | — | — | 1 |
Pulmonary aspergillosis | D055732 | EFO_1001834 | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Muscle strength | D053580 | — | — | — | — | — | — | 4 | 4 |
Resistance training | D055070 | — | — | — | — | — | — | 3 | 3 |
Body composition | D001823 | — | — | — | — | — | — | 3 | 3 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | — | — | — | 3 | 3 |
Skin diseases | D012871 | — | L00-L99 | — | — | — | — | 2 | 2 |
Dermatitis | D003872 | HP_0011123 | L30.9 | — | — | — | — | 2 | 2 |
Infertility | D007246 | HP_0000789 | — | — | — | — | — | 2 | 2 |
Corneal injuries | D065306 | HP_0000559 | — | — | — | — | — | 2 | 2 |
Alopecia areata | D000506 | EFO_0004192 | L63 | — | — | — | — | 2 | 2 |
Alopecia | D000505 | HP_0002293 | L64 | — | — | — | — | 2 | 2 |
Drug common name | Hypromellose |
INN | hypromellose |
Description | Hypromellose (INN), short for hydroxypropyl methylcellulose (HPMC), is a semisynthetic, inert, viscoelastic polymer used in eye drops, as well as an excipient and controlled-delivery component in oral medicaments, found in a variety of commercial products.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL2108956 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 0HO1H52958 (ChemIDplus, GSRS) |